BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 15553067)

  • 1. [Cholestatic liver disease in children].
    Jankowska I; Pawłowska J; Swiatkowska E; Rujner J; Socha J
    Przegl Epidemiol; 2002; 56 Suppl 5():16-21. PubMed ID: 15553067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholestatic liver diseases].
    Reichel C; Meier-Abt PJ
    Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bile acids in liver diseases--current indications].
    Stiehl A
    Ther Umsch; 1995 Oct; 52(10):682-6. PubMed ID: 7482380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
    Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
    Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood--clinical and biochemical effects].
    Kardorff R; Melter M; Rodeck B; Brodehl J
    Klin Padiatr; 1996; 208(3):118-22. PubMed ID: 8676599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.
    Ismail H; Kaliciński P; Markiewicz M; Jankowska I; Pawłowska J; Kluge P; Eliadou E; Kamiński A; Szymczak M; Drewniak T; Revillon Y
    Pediatr Transplant; 1999 Aug; 3(3):219-24. PubMed ID: 10487283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.
    Kaliciński PJ; Ismail H; Jankowska I; Kamiński A; Pawłowska J; Drewniak T; Markiewicz M; Szymczak M
    Eur J Pediatr Surg; 2003 Oct; 13(5):307-11. PubMed ID: 14618520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
    Polzien F; Ramadori G
    J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic therapy with ursodeoxycholic acid in a child with Alagille syndrome].
    Clerici C; Gentili G; Dozzini G; Distrutti E; Solinas A; Vedovelli A; Pelli MA; Bragetti P; Setchell K; Morelli A
    Pediatr Med Chir; 1993; 15(5):521-3. PubMed ID: 8159589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cholestatic liver diseases; the role of ursodeoxycholic acid].
    Stiehl A
    Z Gastroenterol; 1992 Oct; 30(10):743-7. PubMed ID: 1441678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
    Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
    Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of bile formation and cholestatic diseases].
    Poupon R
    Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy.
    Wanty C; Joomye R; Van Hoorebeek N; Paul K; Otte JB; Reding R; Sokal EM
    Acta Gastroenterol Belg; 2004; 67(4):313-9. PubMed ID: 15727074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of cholestatic liver disease.
    Heathcote EJ
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):776-82. PubMed ID: 17628332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS).
    Yousef IM; Perwaiz S; Lamireau T; Tuchweber B
    Med Sci Monit; 2003 Mar; 9(3):MT21-31. PubMed ID: 12640349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.